Serum zinc and copper status in dyslipidaemic patients with and without established coronary artery disease

Clinical Laboratory

Volumn 54, Issue 9-10, 2008, Pages 321-329

  Ghayour Mobarhan, Majid ^a,c,d   Taylor, Andrew ^a   Kazemi Bajestani, Seyyed Mohammad Reza ^d   Lanham New, Susan ^a   Lamb, David J ^a   Vaidya, Nandita ^a,b   Livingstone, Callum ^a,b   Wang, Tim ^a,b   Ferns, Gordon A A ^a,b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dyslipidemic; Heart disease; hs CRP; Trace elements

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; COPPER; MONOUNSATURATED FATTY ACID; ZINC;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORONARY ARTERY DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; DYSLIPIDEMIA; HUMAN; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK FACTOR; VALIDATION PROCESS; ZINC BLOOD LEVEL;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CERULOPLASMIN; COPPER; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; ZINC;

EID: 57149099993     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Craig WY, Poulin SE, Palomaki GE, Neveux LM, Ritchie RF, Ledue TB. Oxidation-related analytes and lipid and lipoprotein concentrations in healthy subjects. Arterioscler Thromb Vasc Biol 1995; 15: 733-739.
2. Ferns GA, Lamb DJ, Avades TY, Taylor A. Copper and atherosclerosis. Metal Ions in Biology and Medicine 2000; 6: 622-624.
3. Ferns GA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 1997; 133:139-152.
4. Stadler N, Lindner RA, Davies MJ. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 2004; 24:949-954.
5. Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality. Epidemiol 2006; 17: 308-314.
6. Singh TK. Serum ceruloplasmin in acute myocardial infarction. Acta Cardiol 1992; 47: 321-329.
7. Cignarelli M, DePergola G, Picca G, et al. Relationship of obesity and body fat distribution with ceruloplasmin serum levels. Int J Obes Relat Metab Disord 1996; 20: 809-813.
8. Kim CH, Park JY, Kim JY, et al. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism 2002; 51:838-842.
9. Zargar AH, Bashir MI, Masoodi SR, et al. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J 2002; 23: 539-542.
10. RothHand Kirchgessner M. Zinc and insulin metabolism. Biol Trace Elem Res 1991; 31: 491-493.
11. Jain VK, Mohan G. Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol Trace Elem Res 1991; 31: 317-322.
12. Arnaud J, Faure H, Bourlard P, Denis B, Favier AE. Longitudinal changes in serum zinc concentration and distribution after acute myocardial infarction. Clin Chim Acta 1994; 230: 147-156.
13. Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr 1975; 28: 764-774.
14. Singh RB, Beegom R, Rastogi, SS., Gaoli Z, Shoumin Z. Association of low plasma concentrations of antioxidant vitamins, magnesium and zinc with high body fat percentage measured by bioelectrical impedance analysis in Indian men. Magnes Res 1999; 11: 3-10.
15. Bialkowaska M, Hoser A, Szostak W, Dybczynski R, Sterlinski S, Nowicka G, Majchrzak J, Kaczorowski J, Danko B. Hair zinc and copper concentration in survivors of myocardial infarction. Ann Nutr Metab 1987; 31(5): 327-332.
16. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65:168-172.
17. Ford ES, Giles WH. Serum C-reactive protein and fibrinogen concentrations and self reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III. J Clin Epidemiol 2000; 53: 95-102.
18. Ghayour-Mobarhan M, New S, Lamb DJ, et al. Dietary antioxidants and fat are associated with plasma antibody titres to heat shock proteins-60, -65 and -70 in subjects with dyslipidaemia and metabolic syndrome. Am J Clin Nutr 2005; 81; 998-1004.
19. New SA, Macdonald HM, Campbell MK et al. Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. Am J Clin Nutr 2004; 79: 131-138.
20. Bodner CH, Soutar A, New SA, Scaife AR, Byres M, Henderson GD, Brown K, Godden DJ. Validation of a food frequency questionnaire for use in Scottish population: correlation of antioxidant vitamin intakes with biochemical measures. J Human Nutr Dieletics 1998; 11(5): 373-380.
21. Bjorntorp P. Abdominal fat distribution and disease: an overview of epidemiological data. Ann Med 1992; 24: 15-18.
22. Friedewald W, Levy R, Fredrickson D. Estimation of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation. Clin Chim Acta 1972; 18: 499-502.
23. Ghayour-Mobarhan M, Taylor A, New S, Lamb DJ, Ferns GAA. Determinants of serum copper, zinc and selenium in healthy subjects. Ann of Clin Biochem 2005; 42(Pt 5): 364-375.
24. Sunderman FW, Nomoto S. Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin Chem 1970; 16: 903-910.
25. Boniface DR, Tefft ME. Dietary fats and 16-year coronary heart disease mortality in a cohort of men and women in Great Britain. Eur J Clin Nutr 2002; 56: 786-792.
26. Esrey KL, Joseph L, Grover SA. Relationship between dietary intake and coronary heart disease mortality; lipid research clinics prevalence follow-up study. J Clin Epidemiol 1996; 49: 211-216.
27. Hu FB, Stampfer MJ, Manson JE. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-1499.
28. Pietinen P, Ascherio A, Korhonen P. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 1997; 145: 876-887.
29. Saadeddin SM, Habbab MA, Ferns GA. Markers of inflammation and coronary artery disease. Med Sci Monit 2002; 8:RA5-12.
30. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
31. Kazemi-Bajestani SMR, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeili H, Ferns GAA. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Clin Lab 2007; 53: 49-56.
32. Kazemi-Bajestani SMR, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeifi H, and Ferns GAA. Serum copper and zinc concentrations are lower in Iranian patients with angiographically defined coronary artery disease. J Trace Elem Med Biol 2007; 21: 22-28
33. Forouhi NG, Sattar N, Mc-Keigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001; 25: 1327-1331.
34. Visser M, Bouter LM, Me Quillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 292: 2131-2135.
35. Ghayour-Mobarhan M, Lamb DJ, Lovell DP, Livingstone C, Wang T, Ferns GA. Plasma antibody titres to heat shock proteins-60, -65 and -70: their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals. Scand J Clin Lab Invest 2005; 65: 601-614
36. Tamakoshi K, Yatsuya H, Kondo T et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003; 27: 443-449.
37. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8-year fallow up of 14719 initially healthy American women. Circulation 2003; 107: 391-397.
38. Adam B, Aslan S, Bedir A, Alvur M. The interaction between copper and coronary risk indicators. Jpn Heart J 2001; 42: 281-286.
39. Abiaka C, Olusi S, Al-Awadhi A. Serum microminerals and the indices of lipid metabolism in an apparently healthy population. J Clin Lab Anal 2003; 17: 61-65.
40. Klevay LM. The influence of copper and zinc on the occurrence of ischemic heart disease. J Environ Pathol Toxicol 1980; 4: 281-287.
41. Klevay LM. Dietary copper and risk of coronary heart disease. Am J Clin Nutr 2000; 71: 1213-1214.
42. Tully CL, Snowdon DA, Markesbery WR. Serum zinc, senile plaques, and neurofibrillary tangles: finding from the Nun Study. Neuroreport 1995; 6: 2105-8.
43. Ghayour-Mobarhan M, Lamb DJ, Taylor A, et al. Effects of statin therapy on trace elements status in dyslipidaemic subjects. J Trace Elem Med Biol 2005; 19: 61-67.
44. Svensson PA, Englund MC, Markstrom E et al. Copper induces the expression of cholesterogenic genes in human macrophages. Atherosclerosis 2003; 169: 71-76.